Chronic fatigue syndrome[edit | edit source]
One study found that 6-8 weeks of Bifidobacterium infantis supplementation reduced C-reactive protein, TNF-alpha and IL-6 levels in CFS patients. Another found that B. infantis boosted serotonin levels in the brain.
FUT2[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
- 2015, Commercial Bifidobacteria probiotics
- 2015, Bifidobacteria role in multiple diseases and gluten allergies
- 2014, Bifidobacterium, Chocolate and CFS
References[edit | edit source]
- Benno et al., 1985
- (Kalliomakiet al., 2001)
- (Kerckhoffs et al., 2009; Rajilić-Stojanović et al., 2011)
- (Wang et al., 2011a)
- Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value
- Groeger, David; O'Mahony, Liam; Murphy, Eileen F.; Bourke, John F.; Dinan, Timothy G.; Kiely, Barry; Shanahan, Fergus; Quigley, Eamonn M. M. (August 2013), "Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut", Gut Microbes, 4 (4): 325–339, doi:10.4161/gmic.25487, ISSN 1949-0984, PMC , PMID 23842110 .
- Secretor Genotype (FUT2 gene) Is Strongly Associated with the Composition of Bifidobacteria in the Human Intestine
chronic fatigue syndrome (CFS) - A controversial term, invented by the U.S. Centers for Disease Control, that generally refers to a collection of symptoms as “fatigue”. There have been multiple attempts to come up with a set of diagnostic criteria to define this term, but few of those diagnostic criteria are currently in use. Previous attempts to define this term include the Fukuda criteria and the Oxford criteria. Some view the term as a useful diagnostic category for people with long-term fatigue of unexplained origin. Others view the term as a derogatory term borne out of animus towards patients. Some view the term as a synonym of myalgic encephalomyelitis, while others view myalgic encephalomyelitis as a distinct disease.